48,836
edits
Difference between revisions of "Lung metastasis"
Jump to navigation
Jump to search
→IHC
(→IHC) |
|||
| Line 22: | Line 22: | ||
*CK20 +ve/-ve (+ve in colorectal carcinoma, -ve in lung primaries). | *CK20 +ve/-ve (+ve in colorectal carcinoma, -ve in lung primaries). | ||
*GATA3 +ve/-ve (usu. +ve in [[urothelial carcinoma]], -ve in lung primaries<ref>{{Cite journal | last1 = Chang | first1 = A. | last2 = Amin | first2 = A. | last3 = Gabrielson | first3 = E. | last4 = Illei | first4 = P. | last5 = Roden | first5 = RB. | last6 = Sharma | first6 = R. | last7 = Epstein | first7 = JI. | title = Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. | journal = Am J Surg Pathol | volume = 36 | issue = 10 | pages = 1472-6 | month = Oct | year = 2012 | doi = 10.1097/PAS.0b013e318260cde7 | PMID = 22982890 }}</ref>). | *GATA3 +ve/-ve (usu. +ve in [[urothelial carcinoma]], -ve in lung primaries<ref>{{Cite journal | last1 = Chang | first1 = A. | last2 = Amin | first2 = A. | last3 = Gabrielson | first3 = E. | last4 = Illei | first4 = P. | last5 = Roden | first5 = RB. | last6 = Sharma | first6 = R. | last7 = Epstein | first7 = JI. | title = Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. | journal = Am J Surg Pathol | volume = 36 | issue = 10 | pages = 1472-6 | month = Oct | year = 2012 | doi = 10.1097/PAS.0b013e318260cde7 | PMID = 22982890 }}</ref>). | ||
*CK7 -ve/+ve (typically positive in lung adenocarcinoma and small carcinoma of the lung; positive in a number of other tumours - breast, upper GI tract, thyroid, mesothelioma, [[salivary gland]]). | |||
==See also== | ==See also== | ||